Covarmed
0673.533.455 · rovalta.com · 09/11/2026
ACTIVE
Covarmed
Financial year 2025 · Closed on 30/09/2025
Net result784,7 k €-25,4 %over 1 year
Gross margin1,9 M €-6,1 %over 1 year
Equity3,1 M €+6,3 %over 1 year
Workforce15,6 ETP+14,7 %over 1 year
Overview
Identity
Source · BCE/KBOCovarmed is a Private limited company incorporated in 2017. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Kortrijk. It employs on average 15,6 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0673.533.455
- Incorporation
- 07/03/2017
- Legal form
- Private limited company
- Registered office
- Doenaertstraat(Mar) 11
8510 Kortrijk · FlandreSee on map - Contributed capital
- 40 800,00 €
- Latest accounts
- 30/09/2025
- Average workforce
- 15,6 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods32500Manufacture of medical and dental instruments and supplies32500Manufacture of medical and dental instruments and supplies47740Retail sale of medical and orthopaedic goods in specialised stores47741Retail sale of medical and orthopaedic goods in specialised stores+4
Joint committees (4)
- 100
- 10000
- 200
- 20000
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 8 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,9 M € | -6.1% | 2,1 M € | +16.2% | 1,8 M € | -7.7% | 1,9 M € | -28.1% | 2,7 M € |
| EBITDA | 1,1 M € | -20.0% | 1,4 M € | +18.4% | 1,2 M € | -17.7% | 1,4 M € | -40.1% | 2,3 M € |
| Operating result | 983 k € | -24.3% | 1,3 M € | +16.4% | 1,1 M € | -17.9% | 1,4 M € | -40.5% | 2,3 M € |
| Net result | 784,7 k € | -25.4% | 1,1 M € | +17.5% | 894,5 k € | -23.4% | 1,2 M € | -35.4% | 1,8 M € |
| Balance sheet | |||||||||
| Equity | 3,1 M € | +6.3% | 2,9 M € | +18.2% | 2,5 M € | +13.5% | 2,2 M € | +70.3% | 1,3 M € |
| Total assets | 4,9 M € | -1.6% | 5 M € | +6.0% | 4,7 M € | -4.8% | 5 M € | +93.6% | 2,6 M € |
| Cash | 1,3 M € | +269% | 359,1 k € | +30.5% | 275,2 k € | -63.6% | 757,2 k € | -45.3% | 1,4 M € |
| Debts | 1,8 M € | -12.8% | 2,1 M € | -7.5% | 2,3 M € | -19.1% | 2,8 M € | +117% | 1,3 M € |
| Other | |||||||||
| Workforce | 15,6 ETP | +14.7% | 13,6 ETP | -1.4% | 13,8 ETP | +15.0% | 12,0 ETP | +25.0% | 9,6 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 5 M€ and 10 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/09/20254 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Managing director02/05/2022 → 12/03/2027 | |||
| Directorsince 13/09/2021 | |||
| Managing directorsince 07/12/2017Director07/12/2017 → 2021 accountsendedManager2018 accountsended | |||
| Managing directorsince 07/12/2017Director07/12/2017 → 2021 accountsendedManager2019 accountsended |
Other companies at this address
Doenaertstraat(Mar) 11 8510 Kortrijk| Company | CBE no. |
|---|---|
COVARMED FARMA● Active | 0835.154.657 |
Curafin● Active | 0685.619.457 |
GROEP TRIHOLD● Active | 0650.699.160 |
Trihold● Active | 0773.345.168 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/04/2026 | 27/01/2025 | 15/04/2024 | 21/03/2023 | 25/01/2022 | 21/04/2021 |
| General meeting | 13/03/2026 | 10/01/2025 | 08/03/2024 | 10/03/2023 | 14/01/2022 | 12/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/09/2025 | 13/03/2026 | 30/04/2026 | Dutch | |
| Abridged model | 30/09/2024 | 10/01/2025 | 27/01/2025 | Dutch | |
| Abridged model | 30/09/2023 | 08/03/2024 | 15/04/2024 | Dutch | |
| Abridged model | 30/09/2022 | 10/03/2023 | 21/03/2023 | Dutch | |
| Abridged model | 30/09/2021 | 14/01/2022 | 25/01/2022 | Dutch | |
| Abridged model | 30/09/2020 | 12/03/2021 | 21/04/2021 | Dutch | |
| Abridged model | 30/09/2019 | 13/03/2020 | 27/04/2020 | Dutch | |
| Abridged model | 30/09/2018 | 08/03/2019 | 11/03/2019 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 5 M€ and 10 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20254 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Managing director02/05/2022 → 12/03/2027 | |||
| Directorsince 13/09/2021 | |||
| Managing directorsince 07/12/2017Director07/12/2017 → 2021 accountsendedManager2018 accountsended | |||
| Managing directorsince 07/12/2017Director07/12/2017 → 2021 accountsendedManager2019 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other14/07/2026DIVERSEN
- Mandates20/05/2026ONTSLAGEN - BENOEMINGEN
- Other15/10/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM
- Mandates12/08/2022ONTSLAGEN - BENOEMINGEN
- Mandates05/01/2022ONTSLAGEN - BENOEMINGEN
- Mandates31/01/2018ONTSLAGEN - BENOEMINGEN
- Other07/04/2017RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings7 filings
Mandates
Marketrading
Trihold
Curafin
Corporalis
20172018201920202021202220232024202520262027
Covarmed
Doenaertstraat(Mar) 11, 8510 Marke
Managing director
Director
Managing directorDirector
Managing directorDirector
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Doenaertstraat(Mar) 11, 8510 MarkeCurrent | accounts 2022 → 2025 | Accounts 2025 · 2026-00103311 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| CovarmedCurrent | accounts 2022 → 2025 | Accounts 2025 · 2026-00103311 |
Events
- 2025Annual accounts 2025784,7 k €↓
- 2024Annual accounts 20241,1 M €↑
- 2023Annual accounts 2023894,5 k €↓
- 2022Annual accounts 20221,2 M €↓
- 2020Annual accounts 20201,8 M €↑
- 2019Annual accounts 2019677,7 k €↓
- 2018Annual accounts 2018754 k €
- 07/03/2017IncorporationPrivate limited company